Sensory-motor neuromodulation of sympathetic vasoconstriction in the rabbit central ear artery.
Histochemical and pharmacological studies were performed on the rabbit central ear artery. In perivascular nerves, positive immunoreactivity for calcitonin gene-related peptide and substance P was demonstrated. Calcitonin gene-related peptide-like immunoreactivity was also found to be colocalised with substance P-like immunoreactivity in a subpopulation of perivascular nerves. In vitro incubation with 6-hydroxydopamine did not alter the intensity and/or density of either the calcitonin gene-related peptide- or substance P-like immunoreactive fibres, whereas incubation with capsaicin significantly reduced both. In pharmacological studies, calcitonin gene-related peptide reduced the vasoconstrictor responses to exogenous noradrenaline and alpha, beta-methylene ATP and to electrical field stimulation in a concentration-dependent manner. In segments of the central ear artery preconstricted with noradrenaline, relaxation mediated by calcitonin gene-related peptide was endothelium-independent. These results shed new light on the innervation and nervous control of the rabbit central ear artery previously thought to be exclusively under sympathetic (adrenergic and purinergic) control. Further, the results suggest that calcitonin gene-related peptide localised in sensory nerves in the rabbit central ear artery may act as an inhibitory modulator of excitatory sympathetic vascular neurotransmission.
Department of Anatomy and Developmental Biology, University College London, U.K.
K I
KI
Maynard
V L
VL
Saville
G
G
Burnstock
D000244:Adenosine Diphosphate / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D015740:Calcitonin Gene-Related Peptide / Q000494:pharmacology; D002395:Catecholamines / Q000378:metabolism; D004423:Ear / Q000098:blood supply; D004558:Electric Stimulation; D005453:Fluorescence; D006651:Histocytochemistry; D066298:In Vitro Techniques; D008297:Male; D008856:Microscopy, Fluorescence; D009046:Motor Neurons / Q000502:physiology*; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000294:innervation*; D009475:Neurons, Afferent / Q000502:physiology*; D011817:Rabbits; D012039:Regional Blood Flow / Q000187:drug effects; D013194:Staining and Labeling; D013373:Substance P / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000502:physiology*; D009435:Synaptic Transmission / Q000502:physiology; D014661:Vasoconstriction / Q000502:physiology*
D002395:Catecholamines; C523965:alpha,beta-methyleneadenosine 5'-diphosphate; D013373:Substance P; D000244:Adenosine Diphosphate; D015740:Calcitonin Gene-Related Peptide